Similar articles

• [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].

  Manger B; Kommission Pharmakotherapie, Deutschen Gesellschaft für Rheumatologie. Manger B, et al. Z Rheumatol. 2002 Dec;61(6):698-700. doi: 10.1007/s00393-002-0452-0. Z Rheumatol. 2002. PMID: 12491134 Review. German. No abstract available.
• [Anakinra for therapy of rheumatoid arthritis].

  Tomoo T, Sumida T. Tomoo T, et al. Nihon Rinsho. 2005 Jan;63 Suppl 1:534-7. Nihon Rinsho. 2005. PMID: 15799413 Review. Japanese. No abstract available.
• Anakinra (Kineret) for rheumatoid arthritis.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2002 Feb 18;44(1124):18-9. Med Lett Drugs Ther. 2002. PMID: 11856953 No abstract available.
• The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.

  Cohen SB. Cohen SB. Rheum Dis Clin North Am. 2004 May;30(2):365-80, vii. doi: 10.1016/j.rdc.2004.01.005. Rheum Dis Clin North Am. 2004. PMID: 15172046 Review.
• [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].

  Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ. Zoń-Giebel A, et al. Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.